Epidemiology

A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis

Dae Hyun Yoo, Chang-Hee Suh, Seung Cheol Shim, Slawomir Jeka, Francisco Fidencio Cons-Molina, Pawel Hrycaj, Piotr Wiland, Eun Young Lee, Francisco G Medina-Rodriguez, Pavel Shesternya, Sebastiao Radominski, Marina Stanislav, Volodymyr Kovalenko, Dong Hyuk Sheen, Leysan Myasoutova, Mie Jin Lim, Jung-Yoon Choe, Sang Joon Lee, Sung Young Lee, Taek Sang Kwon, Won Park

10.1136/annrheumdis-2016-209540

September 13, 2016

Association between rheumatoid arthritis disease activity, progression of functional limitation and long-term risk of orthopaedic surgery: combined analysis of two prospective cohorts supports EULAR treat to target DAS thresholds

Elena Nikiphorou, Sam Norton, Adam Young, Lewis Carpenter, Josh Dixey, David Andrew Walsh, Patrick Kiely, on behalf of ERAS and ERAN, Paul Davies, Lynn Hill, Andrew Gough, Joe Devlin, Paul Emery, Lynn Waterhouse, David James, Helen Tate, Peter Prouse, Cathy Boys, Peter Williams, Dora White, Helen Dart, Nigel Cox, Sue Stafford, John Winfield, Annie Seymour, Annie Seymour, Richard Williams, Karina Blunn, Jackie McDowell, Peter Prouse, Sheryl Andrews, Deborah Wilson, Malgorzata Magliano, Ursula Perks, Amanda Coulson, Andrew Hassle, Michele Kirwan, Francesca Leone, Ciaran Dunne, Lindsey Hawley, Paul Creamer, Julie Taylor, Wendy Wilmott, Sally Knights, Rebecca Rowland-Axe, Sandra Green, Dawn Simmons, Joel David, Maureen Cox, Marwan Bukhari, Bronwen Evans, Michael Batley, Catherine Oram, Tanya Potter

10.1136/annrheumdis-2015-208669

March 15, 2016